GLP-1 also helps manage blood sugar in people with type 2 diabetes, and individuals that are overweight or obese
The same mechanism may explain why the risk appears highest in the first year of therapy when metabolic improvements are most rapid and why the signal seems stronger with more potent agents
I should stop as soon as I hit my goal weight. Stopping immediately at goal weight often increases rebound risk
Monitoring, Screening, and When to Get Help for Mood Problems Prescribers should screen for depression and suicidality before starting Tirzepatide and check mood at follow-up visits, especially in the first 8 to 12 weeks when dose changes and rapid weight loss occur
On the community-reported low-dose protocol (~50mcg/day loading, then 250mcg 1-2/week), only about 1-2mg of mass is used in any 28-day window so every common vial holds far more than the window allows, and the window, not the dose, is always the limiter: Practical implication: because so little is used per 28-day window, a 5mg vial or staged reconstitution of a larger vial minimizes waste